Norah Lynn Henry, MD, PhD, FASCO

Cancer.Net Associate Editor: Breast Cancer
Huntsman Cancer Center, Salt Lake City, UT

Dr. Norah Lynn Henry is an Associate Professor in the University of Utah's Division of Oncology in the Department of Internal Medicine. She is Leader of the Women’s Cancers Disease Center at the Huntsman Cancer Institute (HCI). Dr. Henry specializes in the care of patients with all stages of breast cancer.

Dr. Henry’s research focuses on personalizing treatment for breast cancer. She studies treatments for breast cancer as well as ways to manage symptoms and side effects that arise from the cancer or its treatment. In addition, she works with scientists at HCI and the University of Utah to translate their lab findings into clinical trials. She is also active in the National Cooperative Group SWOG (the Southwest Oncology Group), where she is Co-Chair of the Symptom Management and Quality of Life Committee, and in ASCO, where she serves on the Cancer Survivorship Committee and the Nominating Committee, in addition to this role.

Dr. Henry has been at the University of Utah since October 2016. Before coming to HCI, Dr. Henry cared for patients and performed research in breast cancer and symptom management at the University of Michigan.

Disclosure: In the past two years, Dr. Henry’s institution received research funding from Abbvie, BioMarin, Innocrin Pharmaceuticals, and Pfizer.

Last updated: August 2018